(Date:11/23/2009)...ble in German . , Of all global carbon diox...mosphere where it contributes to global warming. T...ial ecosystems such as forests, grasslands and pea...c and terrestrial ecosystems is considered one of ...limate change. However, new greenhouse gas bookkee...
(Date:11/22/2009)...ne deletion can increase the likelihood of immune ...n, an international team of researchers reports in...enetics . When the gene, called UGT2B17, is missin...ient,s, transplants have a significantly greater r...-host disease, in which immune cells from the dono...
(Date:11/21/2009)...ember 20,2009 / b3c newswire / - KINAXO Biotechn...ing round, gaining two new investors in the compan...AXO reports that Jrgen Schumacher has been elected..., KINAXO shareholders Axel Ullrich, Hellmut Kirch...utional investors Mountain Partners, BioM, High-Te...
Breaking Biology News(10 mins):Intensive land management leaves Europe without carbon sinks 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Houston Dermatologists to Round Up for Sun Safety at World Class LPGA Tour Championship 61451 1Houston Dermatologists to Round Up for Sun Safety at World Class LPGA Tour Championship 61451 2Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 1Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 2Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 3Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 4Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 5Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 1Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 2Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 3Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 4Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 5(Date:11/20/2009)...PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (...he Ninth Circuit Court of Appeals reversed a U.S. ...allowed to pursue all of its claims against The La...urt for trial. CTI filed a complaint against The ... consultant for CTI,s product TRISENOX, in 2007 se...
(Date:11/19/2009)...Newswire/ -- Danish Prince Joachim inaugurated the...in Kalundborg, Denmark, on Wednesday, November 18....est 2nd generation ethanol demonstration biorefine...he plant,s innovative process for converting straw... first to market with commercial enzymes for conve...
(Date:11/19/2009)...ewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: N...ng letter to its shareholders, discussing the Comp...iopharmaceuticals Holdings, Inc. (CHBP), an integr...e,s Republic of China. The merger gives NeoStem a ...ical Co. Ltd., CHBP,s primary operating subsidiary...
(Date:11/19/2009)...ewswire/ - Aegera Therapeutics Inc. announced toda...Phase 2B study of AEG35156, a targeted antisense t...ncology indications. ,, The study, entitled "An...ed Inhibitor of Apoptosis (XIAP) Antisense AEG3515...nd Idarubicin in AML Following Failure of a Single...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2...ETA, Calif., April 9 Copan Diagnostics, Inc. is p...: Walk-Away Specimen Processor in Canada at Vancou...cimen Processor is a revolutionary system for auto... The breakthrough technology behind the WASP, coup...ab system for automation, make the WASP the first ...
...EIJING, April 9 /PRNewswire-Asia/ -- Sinovac Biote...nd provider of vaccines in China, today announced,...three and twelve month,periods ended December 31, ... -- Record full year 2008 sales increasing 39% y...6.93 million doses of Healive(R) in 2008, up from ...
...O, Calif., April 9 BioMarin Pharmaceutical Inc. (... Bienaime, Chief Executive Officer of BioMarin, wi... April 30, at 5:00 p.m. ET (23:00 CET) to discuss ...S. / Canada Dial-in Number: 866.383.7998, Inte...ipant Code: 63957862, Replay Dial-in Number: 88...
Other Biology Technology:Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 3Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 4Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 5Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 6Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 7Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 8Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 9Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 10Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 11Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 12Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 13Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 14Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 15Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 16Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 17Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 18BioMarin to Host First Quarter 2009 Financial Results Conference Call and Webcast on Thursday, April 30 at 5:00 p.m. ET (23:00 CET) 2...ystems Cell and Tissue Staining Kits are intended ...istological and cytological specimens. These kits ...ed by either R&D Systems or by other vendors. Brie...idin-Biotin Complex (ABC) with primary antibodies ...
microTOFLC from Bruker Daltonics
...lar uptake of long double stranded RNA (dsRNA) has...e group of organisms as well as insect cells in cu... protein expression by utilizing sequence-specific...er RNA (mRNA). Attempts to induce RNA interference...
...r Daltonics and Bruker BioSpins Metabolic Profiler... and analysis of complex mixtures. It features an ...MR spectrometer and integrated software for data a...r applications like:,Assessment of the metabolic p...
Biology Products: